Mobius3D quality assurance software receives FDA clearance

Mobius Medical Systems has announced that it has received FDA 510(k) clearance for its Mobius3D quality assurance software.

The software, which is used for treatment plan verification in radiation therapy, calculates 3D radiation dose based on previous plans and log data using an independently developed quality algorithm.

“Mobius3D is the result of several years of development and testing,” said company founder Nathan Childress, PhD, in a press release. “We are very pleased with the FDA clearance and look forward to showing clinicians in the U.S. the vast improvements Mobius3D provides in the safety and effectiveness of patient treatments.”

MobiusFX, an optional add-on for the system which utilizes the same collapsed-cone algorithm files to determine 3D dose delivered to the patient, was also included in the FDA clearance.

Read the full announcement.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup